Other Tumors Could Be Halted By Breast Cancer Drug

Well known for attacking a protein associated with the spread of breast cancer is the drug, geldanamycin. A laboratory-based study however has found it also degraded a different protein that triggers blood vessel growth.

Stopping unwanted blood vessel growth is a key challenge in the battle against cancer, according to Dr Sreenivasan Ponnambalam, reader in human disease biology in the University of Leeds' Faculty of Biological Sciences. "This is potentially very significant because tumours secrete substances that stimulate blood vessels to develop around them, forming networks that supply nutrients and provide pathways for spread around the body," Dr Ponnambalam said. "This is one of the big problems in cancer: how can we stop the tumour growing and spreading through these blood vessel networks?"

"There are already other drugs available that try to stop this growth. One type tries to attack directly the membrane protein VEGFR2, which is essential for new blood vessel growth. However, that approach carries the risk of serious side-effects because proteins in the membrane walls of blood vessels do important work such as controlling blood pressure. Geldanamycin offers a novel and potentially safer solution because it suppresses the protein indirectly. The new study, based on experiments with human cells and different animal models, found that geldanamycin indirectly triggered the clearance of the VEGFR2 protein by activating a cellular quality-control system that breaks down many proteins".

That quality-control system already degrades VEGFR2 relatively slowly but the drug accelerates the process, preventing activation of the protein and inappropriate new blood vessel formation. "With conventional treatments, we have been trying to deal with the situation after the switch has been thrown. What this drug does is destroy the key part of the switch before that switch is thrown," Dr Ponnambalam said. "Geldanamycin and chemical derivatives have been under intensive study in the laboratory and in clinical trials for the past 20 years. The cost to the NHS or patients could be relatively low compared to the expensive existing anti-cancer drugs, which are still under patent," Dr Ponnambalam added.

Source: Eurekalert

Screening for Breast Cancer with Clinical Breast Examination

Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.

Breast Cancer during Pregnancy

Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.

Breast Cancer - Prevention and Management with Lifestyle Changes

Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.

Breast Cancer Screening using Mammogram

Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

Breast Biopsy

Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or benign.

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Mastitis

Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the mammary gland, Breast infection may occur in some cases.

Pagets disease of the breast

A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, detection methods and treatment modalities. Risk factors and FAQs are all included.

Women and Cancer

Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.